| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 01/28/2010 | US20100021439 Methods and compositions for treating intervertebral disc degeneration |
| 01/28/2010 | US20100021438 Kidney derived stem cells and methods for their isolation, differentiation and use |
| 01/28/2010 | US20100021437 Neural stem cells derived from induced pluripotent stem cells |
| 01/28/2010 | US20100021436 Multipotent adult stem cell derived from canine umbilical cord blood, placenta and canine fetus heart, method for preparing the same and cellular therapeutics containing the same |
| 01/28/2010 | US20100021435 Pancreatic islet-like cells |
| 01/28/2010 | US20100021434 Isolated Oligodendrocyte-Like Cells and Populations Comprising Same for the Treatment of CNS Diseases |
| 01/28/2010 | US20100021432 Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells with a Virus |
| 01/28/2010 | US20100021431 Agent for Promoting the Production of Thioredoxin |
| 01/28/2010 | US20100021430 Horse feed and treatment methods |
| 01/28/2010 | US20100021422 Methods and compositions for delivery of exogenous factors to nervous system sites |
| 01/28/2010 | US20100021416 Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders |
| 01/28/2010 | DE102008034944A1 Mikroemulsion Microemulsion |
| 01/28/2010 | CA2736842A1 Proteins for use in diagnosing and treating infection and disease |
| 01/28/2010 | CA2731821A1 Compositions for mesoderm derived isl1+ multipotent cells (imps), epicardial progenitor cells (epcs) and multipotent cxcr4+cd56+ cells (c56cs) and methods of use |
| 01/28/2010 | CA2731541A1 Probiotics to increase iga secretion in infants born by caesarean section |
| 01/28/2010 | CA2731500A1 Glycolipid fraction from cyanobacteria for treatment of diseases of the oral cavity |
| 01/28/2010 | CA2731237A1 A collagen scaffold for cell growth and a method for producing same |
| 01/27/2010 | EP2147681A1 Compositions and methods for treating lysosomal storage disease |
| 01/27/2010 | EP2147678A1 Probiotics to increase IgA secretion in infants born by caesarean section |
| 01/27/2010 | EP2147677A1 Eradicating agent for helicobacter pylori |
| 01/27/2010 | EP2147094A1 Stem cell-derived retinal pigment epithelial cells |
| 01/27/2010 | EP2147091A2 Broad-spectrum antibacterial and antifungal activity of lactobacillus johnsonii d115 |
| 01/27/2010 | EP2146728A2 Progenitor cells from urine and methods for using the same |
| 01/27/2010 | EP2146727A1 High viscosity macromolecular compositions for treating ocular conditions |
| 01/27/2010 | EP1206563B1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 01/27/2010 | CN101636173A Methods and kits for administering probiotics |
| 01/27/2010 | CN101636172A Product containing inactivated probiotic for children or infants |
| 01/27/2010 | CN101636171A Serum preparation method and serum preparation apparatus |
| 01/27/2010 | CN101633907A Amplification culture method for antigen specific cytotoxic t lymphocytes |
| 01/27/2010 | CN101632690A Medicine for treating sepsis |
| 01/27/2010 | CN101632689A Colorless medicinal wine for regulating balance of yin and yang of human body and preparation method thereof |
| 01/27/2010 | CN101632688A Method for preparing anti-dengue fever oral preparation by applying medicament-loaded nano-magnetic microspheres |
| 01/27/2010 | CN101632687A Process for preparing deer horn glue |
| 01/27/2010 | CN100584945C Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 01/27/2010 | CN100584940C Strain for producing arginine deiminase and application thereof |
| 01/27/2010 | CN100584832C 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders |
| 01/27/2010 | CN100584373C Preparation process of medicine for treating cerebral apoplexy and its sequela |
| 01/27/2010 | CN100584372C External use traditional Chinese medicine ointment for treating heart diseases |
| 01/27/2010 | CN100584371C Chinese-western medicine composition containing carafate for treating gastric ulcer |
| 01/27/2010 | CN100584370C Traditional Chinese medicine for treating digestive cancer |
| 01/27/2010 | CN100584369C Composition of Chinese traditional medicine for treating rheumatism |
| 01/27/2010 | CN100584368C Medicine for treating rheumatoid and rheumatoid arthritis and its preparation method |
| 01/27/2010 | CN100584364C A blood circulation-invigorating tendon-strengthening capsule and preparation process thereof |
| 01/27/2010 | CN100584362C Traditional Chinese medicine for treating leukocythemia |
| 01/27/2010 | CN100584360C Chinese medicine composition for treating oral inflammation |
| 01/27/2010 | CN100584356C Musk containing medicine composition |
| 01/27/2010 | CN100584354C A medicine for treating zoster sequela neuralgia |
| 01/27/2010 | CN100584351C Anticancer medicine and its preparation |
| 01/27/2010 | CN100584344C Biological stagnation-removing proprietary Chinese medicine and its producing method |
| 01/27/2010 | CN100584343C Medicine health-care usage of globefish I collagen extraction and preparing process thereof |
| 01/27/2010 | CN100584342C Use of natural killer T cells in preparing immunological rejection medicine for cornea transplantation of mammal |
| 01/27/2010 | CN100584341C Method for masking stench of animal traditional Chinese medicinal formulation granule |
| 01/27/2010 | CN100584320C Chinese traditional medicine for treating rheumatoid disease and osteoarthritis and preparation method |
| 01/27/2010 | CN100584312C Attapulgite pleuropterus cordatus shampoo |
| 01/26/2010 | US7652077 Graft prosthesis, materials and methods |
| 01/26/2010 | US7652068 Omega 3 fatty acid formulations |
| 01/26/2010 | US7651998 administering a Venezuelan Equine Encephalitis (VEE) vector (alpha virus vector) comprising a heterologus nucleotide sequence to a subject; concurrently administering an antibody that specifically binds to the E1 and/or the E2 glycoprotein of the VEE vector to produce immune response to cancer patient |
| 01/26/2010 | US7651855 Ex vivo activated; provide sufficient amounts of culture expanded isolated CD4+CD25+ suppressor Treg cells; long term suppressor capability; therapeutic prevention, blocking, inhibiting the rejection of transplanted tissue, protecting against graft vs host disease; donor cells allogeneically introduced |
| 01/26/2010 | US7651853 Cultures of GFAP+ nestin+ cells that differentiate to neurons |
| 01/26/2010 | US7651684 Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
| 01/26/2010 | US7651680 Methods and compositions for preventing and treating sensitive and dry skin |
| 01/26/2010 | US7651656 Melting furnace with agitator and agitator for melting furnace |
| 01/26/2010 | CA2496080C Plasmid-free clone of e. coli strain dsm 6601 |
| 01/26/2010 | CA2421588C Tnf receptor-like molecules and uses thereof |
| 01/26/2010 | CA2393315C A process for preparing an autologous platelet gel and membranes thereof, and a kit for carrying out this process |
| 01/26/2010 | CA2349629C Methods for the production of tcr gamma delta t cells |
| 01/26/2010 | CA2319447C Embolization device |
| 01/26/2010 | CA2309907C Method for inducing osteoblast differentiation of human extramedullary adipose tissue cells |
| 01/26/2010 | CA2162305C Method of increasing viability of stored erythrocytes by addition of lipoic, dihydrolipoic, 6,8-bisnortetralipoic or tetranorlipoic acid |
| 01/21/2010 | WO2010008879A2 Probiotic chewing gum method of manufacture |
| 01/21/2010 | WO2010008491A2 Lactose compositions with decreased lactose content |
| 01/21/2010 | WO2010008459A1 Protein kinase inhibitors |
| 01/21/2010 | WO2010008278A1 Treatment of gut motility disorders |
| 01/21/2010 | WO2010008272A1 Treatment of gut motility disorders |
| 01/21/2010 | WO2010008243A2 Method for preparing livestock excreta condensate, and livestock excreta condensate thereof |
| 01/21/2010 | WO2010008113A1 Anti-cancer composition comprising a culture fluid of lactobacillus casei as an effective component |
| 01/21/2010 | WO2010008005A1 Agent for ameliorating immune system function abnormality induced by stress |
| 01/21/2010 | WO2010007620A1 Pharmaceutical composition comprising porcine brain extract |
| 01/21/2010 | WO2010007332A2 Composition of soluble indigestible fibre and of eukaryotic organisms with a polysaccharide wall, used in the well-being field |
| 01/21/2010 | WO2010007331A2 Composition of soluble indigestible fibre and of microalgae used in the well-being field |
| 01/21/2010 | WO2010007198A1 Bacteria and derived products to strengthen defences and reduce risk of illness |
| 01/21/2010 | WO2009137159A3 Bioactive molecules produced by probiotic bacteria |
| 01/21/2010 | WO2009117116A3 Heat shock protein gp96 vaccination and methods of using same |
| 01/21/2010 | WO2009104911A4 Uses as agents for prophylaxis or treatment of cervical cancer |
| 01/21/2010 | WO2009061447A3 Use of umbilical cord blood in the treatment of premature birth complications |
| 01/21/2010 | WO2009050677A3 Use of lactic bacteria for the prophylaxis and/or treatment of skin diseases |
| 01/21/2010 | WO2008134450A3 Broad-spectrum antibacterial and antifungal activity of lactobacillus johnsonii d115 |
| 01/21/2010 | US20100016836 Methods and Apparatus for Acute or Chronic Delivery or Substances or Apparatus to Extravascular Treatment Sites |
| 01/21/2010 | US20100016833 Devices for the Treatment of Vascular Aneurysm |
| 01/21/2010 | US20100016549 Peyer's patch and/or m-cell targeting ligands |
| 01/21/2010 | US20100015712 Side population cells originated from human amnion and their uses |
| 01/21/2010 | US20100015700 Use of the adenoviral e2 late promoter |
| 01/21/2010 | US20100015593 Method for producing a composition for promoting survival of transplanted hematopoietic stem cell |
| 01/21/2010 | US20100015263 Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders |
| 01/21/2010 | US20100015243 Method for preparing materials having antithrombotic activity from muskrat musk and materials obtained from the method |
| 01/21/2010 | US20100015242 Use of a composition for skin treatment under x-irradiation |
| 01/21/2010 | US20100015212 Immunogenic bacterial vesicles with outer membrane proteins |
| 01/21/2010 | US20100015204 Cell carrier and cell carrier containment devices containing regenerative cells |
| 01/21/2010 | US20100015202 Cancellous construct with support ring for repair of osteochondral defects |
| 01/21/2010 | US20100015200 Drug Delivery Medical Device |